New Drugs Hold Promise Against Drug-Resistant TB
Tuberculosis (TB) is the world's oldest known infectious disease and the one that kills the most people today, about two million a year. Yet, no n...
Tuberculosis (TB) is the world's oldest known infectious disease and the one that kills the most people today, about two million a year. Yet, no n...
The TB Alliance is teaming up with researchers at the University of Illinois at Chicago (UIC) College of Pharmacy to develop third generation macrolid...
Policy discussions on new drugs and R&D have taken on new urgency because of recent policy papers and upcoming key events. In the lead-up to the A...
The Global Alliance for TB Drug Development (TB Alliance) and Novartis Institute for Tropical Diseases (NITD) announced their plans to pursue a joint ...
The Global Alliance for TB Drug Development plans to team up with a unit of Novartis AG to speed development of much-needed new drugs to treat tubercu...
A class of drug, which is currently used to fight respiratory tract infections, has demonstrated pharmacological features and potential antibacterial ...
SAC Member Wins Prestigious AwardDr. Ramesh Panchagnula, Ph.D., member of the Global Alliance for TB Drug Development's Scientific Advisory Commit...
NEW YORK, NY – OCT 20, 2004 – The Global Alliance for TB Drug Development (TB Alliance), a public-private partnership developing faster-ac...
New Donor Brings Support for Innovative Drug Development to $50 million The United States Agency for International Development (USAID), the lea...
Each year, the international TB community gathers together at the UNION World Conference on Lung Health to discuss TB and lung health issues, and shar...